文献速递药疹与重症皮肤不良反应

抗癫痫药物相关Stevens-Johnson综合征与中毒性表皮坏死松解症比例:Meta分析

Proportion of Antiepileptic Drug-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.
PubMed 文献 · JAMA Dermatol · 2026-01-01

该系统评价与Meta分析纳入50项研究、共4403例报告患者层面诱因的SJS/TEN病例,估计抗癫痫药物(AEDs)相关SJS/TEN的合并比例为23%(95%CI 19-26)。AED相关病例几乎均由芳香族AEDs引起(96%),以卡马西平最常见(39%),儿童比例高于成人,且存在显著地域差异。

要点

  • AEDs约占全球SJS/TEN病例的近四分之一,以芳香族AEDs为主。
  • 芳香族AEDs中卡马西平39%、苯妥英19%、拉莫三嗪15%最常见。
  • 儿童AED相关比例(35%)显著高于成人(23%)。

核心结论

  • AEDs占全球报告的SJS/TEN病例近四分之一,主要由芳香族AEDs(卡马西平、苯妥英、拉莫三嗪)引起。
  • 研究结果支持在临床合适时优先选用非芳香族AEDs。

研究设计与样本

  • 系统评价与随机效应Meta分析,检索MEDLINE与Embase自建库至2026年3月17日,限英文文献与人类研究。
  • 纳入50项报告患者层面SJS/TEN诱因的实验与观察性研究,共4403例患者。
  • 由两名评价者独立筛选文献并提取数据,按年龄组与地理区域进行亚组分析。

主要发现

  • 单药诱因占SJS/TEN病例的88%(95%CI 83-92)。
  • AEDs相关SJS/TEN合并比例为23%(95%CI 19-26)。
  • AED相关病例中芳香族AEDs占96%(95%CI 92-99),非芳香族AEDs仅2%(95%CI 0-4)。
  • 芳香族AEDs中卡马西平占39%(95%CI 29-50)、苯妥英19%(95%CI 11-28)、拉莫三嗪15%(95%CI 8-22)。
  • AED相关比例存在地域差异,西亚为42%(95%CI 26-59)、非洲为10%(95%CI 0-33)(P < .001);儿童为35%(95%CI 22-48)高于成人的23%(95%CI 20-27)。

关键数值与推荐

  • AED相关SJS/TEN合并比例为23%(95%CI 19-26)。
  • 芳香族AEDs占AED相关病例96%(95%CI 92-99);卡马西平39%(95%CI 29-50)、苯妥英19%(95%CI 11-28)、拉莫三嗪15%(95%CI 8-22);非芳香族AEDs 2%(95%CI 0-4)。
  • 儿童AED相关比例为35%(95%CI 22-48),成人为23%(95%CI 20-27)。
  • 地域比例自西亚42%(95%CI 26-59)至非洲10%(95%CI 0-33),P < .001。

临床怎么用

  • 对需使用抗癫痫药物的患者,尤其儿童,应警惕芳香族AEDs相关SJS/TEN风险。
  • 在临床合适时优先考虑非芳香族AEDs以降低SJS/TEN风险。
  • 处方芳香族AEDs前应结合地域与人群风险进行获益风险评估。

局限性

  • 纳入研究以观察性研究为主,AED相关比例的估计可能受各研究诱因判定与报告差异影响。
  • 仅纳入英文文献,可能存在语言偏倚。
  • 亚组间异质性明显(地域与年龄),合并比例的解释需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Antiepileptic drugs (AEDs) are frequently implicated in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are the most severe type of drug hypersensitivity reaction, with a mortality rate up to 50%. However, the overall proportion of these cases attributed to AEDs has not been systematically reviewed. OBJECTIVE: To evaluate the proportion of AED-associated SJS/TEN. DATA SOURCES: The MEDLINE and Embase databases were searched from inception through March 17, 2026, with results limited to English-language publications and human participants. STUDY SELECTION: All experimental and observational studies that reported patient-level triggers of SJS/TEN were included. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently screened studies and extracted data using a predefined template. To estimate the proportion of AED-associated SJS/TEN, a random-effects meta-analysis was performed, calculating the pooled proportions with 95% CIs. Subgroup analyses by age group (children vs adults) and geographic region were performed to explore heterogeneity. MAIN OUTCOMES AND MEASURES: To estimate the proportion of AED-associated SJS/TEN. RESULTS: This systematic review and meta-analysis included 50 studies with 4403 patients that reported patient-level triggers of SJS/TEN. Single-drug triggers accounted for 88% (95% CI, 83-92) of cases. The pooled proportion of SJS/TEN cases attributed to AEDs was 23% (95% CI, 19-26). Nearly all AED-associated cases were due to aromatic AEDs (96%; 95% CI, 92-99), most commonly carbamazepine (39%; 95% CI, 29-50), followed by phenytoin (19%; 95% CI, 11-28), and lamotrigine (15%; 95% CI, 8-22). Nonaromatic AEDs were rarely implicated (2%; 95% CI, 0-4). Significant geographic variation was observed in the proportion of AED-associated SJS/TEN, ranging from 42% (95% CI, 26-59) in West Asia to 10% (95% CI, 0-33) in Africa (P < .001). The proportion of AED-associated SJS/TEN cases was significantly higher in children (35%; 95% CI, 22-48) than in adults (23%; 95% CI, 20-27). CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis of observational studies, AEDs accounted for nearly one-quarter of SJS/TEN cases reported worldwide, predominantly involving aromatic AEDs, such as carbamazepine, phenytoin, and lamotrigine. These findings suggest aromatic AEDs as leading contributors to SJS/TEN and support the preferential use of nonaromatic AEDs when clinically appropriate.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Lee EY, Knox C, Sugumar C, et al. Proportion of Antiepileptic Drug-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis. JAMA Dermatol. 2026. PMID: 42485011. doi:10.1001/jamadermatol.2026.2473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。